Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT05999942 Completed - Healthy Volunteers Clinical Trials

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Start date: June 2, 2004
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to determine the intra and extra pulmonary deposition and clearance of inhaled amikacin-loaded liposomes by gamma scintigraphy in healthy male participants.

NCT ID: NCT05995691 Completed - Healthy Volunteers Clinical Trials

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Start date: November 24, 2014
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to determine the bioequivalence of ABP 501 (subcutaneous [SC] injection) compared to adalimumab (SC injection) as assessed principally by the area under the serum concentration-time curve from time 0 extrapolated to infinity (AUCinf), and maximum observed serum concentration (Cmax) in Japanese participants.

NCT ID: NCT05995444 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects

Start date: June 5, 2023
Phase: Phase 1
Study type: Interventional

A single-center, 4-way crossover study to evaluate the effect of single therapeutic and supratherapeutic oral doses of epetraborole on the heart rate (HR) corrected QT interval (QTc) by assessing concentration-QT (C-QT) relationship using exposure-response modeling.

NCT ID: NCT05995366 Completed - Healthy Volunteer Clinical Trials

A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

Start date: August 18, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the mass balance and safety of [14C] ABBV-903 in healthy male volunteers following a single oral dose administration.

NCT ID: NCT05995249 Completed - Healthy Volunteers Clinical Trials

A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

Start date: August 11, 2023
Phase: Phase 1
Study type: Interventional

The main aim of this study is to find out how the body of a healthy adult processes TAK-279 (pharmacokinetics) when substances that either hinder or help the human metabolism such as erythromycin, phenytoin and efavirenz are given along with TAK-279. Other aim is to learn about side effects and how well it is tolerated when TAK-279 is given alone and together with substances that impact human metabolism. The participants will need to stay at the clinic for up to 26 days.

NCT ID: NCT05995119 Completed - Healthy Volunteers Clinical Trials

Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers

Start date: December 5, 2022
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the pharmacokinetic profiles and bioequivalence, and to determine the safety and tolerability of the TAH3311 Oral Dissolving Film (ODF) 5mg compared with ELIQUIS® (Apixaban) 5mg Oral Tablet, after single dose under fasted and fed conditions in healthy volunteers.

NCT ID: NCT05994807 Completed - Healthy Volunteers Clinical Trials

A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants

Start date: August 8, 2023
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to assess the effect of a cytochrome P450 3A4 (CYP3A4) inhibitor (itraconazole) and CYP3A4 inducer (carbamazepine) on the single dose pharmacokinetics (PK) of DC-806 coadministered with itraconazole or carbamazepine in healthy male and female participants.

NCT ID: NCT05992155 Completed - Healthy Volunteers Clinical Trials

A Study of TAK-279 in Adults With or Without Kidney Problems

Start date: September 27, 2023
Phase: Phase 1
Study type: Interventional

The main aim of this study is to find out how the body processes 1 dose of TAK-279 (pharmacokinetics) in participants with kidney problems compared to participants without kidney problems. Other aims are to check for side effects from TAK-279 and to learn how well participants tolerate 1 dose of TAK-279. The participants will need to stay at the clinic for 11 days.

NCT ID: NCT05991362 Completed - Healthy Volunteer Clinical Trials

A Phase I Study of GFH312 in Healthy Chinese Subjects

Start date: November 29, 2022
Phase: Phase 1
Study type: Interventional

The aim of this study was to evaluate the pharmacokinetic profile and observe the safety of GFH312 after single and multiple administrations in healthy Chinese subjects.

NCT ID: NCT05988268 Completed - Healthy Volunteers Clinical Trials

Effects of 6-Week Vibration and Non-Vibration Foam Rolling

Start date: August 7, 2023
Phase: N/A
Study type: Interventional

This study aims to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players.